Agarikon Conk - Tree Fungus with Medicinal Ambitions

By Dr. Markho Rafael

In a fascinating broadcast on National Public Radio, internationally renowned medicinal mushroom expert Paul Stamets tells his story of discovering the medicinal potential of agarikon, an extremely rare and threatened species of wood conk that requires century-old trees to grow. Agarikon is today all but extinct in Europe, its remaining distribution limited to the old growth forests on the North American West Coast.

Scientists have known for some time that mushrooms are not plants. Far from it. They are more closely related to animals and humans then they are to the vegetables we eat. Because of that, they are often at risk from the same bacteria and other "bugs" that cause diseases in humans. Being well aware of this fact, Stamets asked himself how agarikon - a perennial mushroom living for up to 50 years - managed to fight off diseases so well in the perpetually wet rainforests. It must possess a potent immune system, he concluded, with potential anti-bacterial and anti-viral compounds that may act as antibiotics for humans.

Stamets describes the agarikon conk as looking like a bee hive when viewed from the ground. Remember, they grow on the trunks of ancient tree giants, sometimes high up. (Use the agarikon-link on this page to view a picture of Paul Stamets holding an agarikon mushroom.) Please be aware that this is a threatened species and should be left alone in most cases. Just get out your digital camera if you are lucky enough to find a specimen. (Otherwise, no one may believe you.)

Paul Stamets now grows his own agarikon, which he uses for his agarikon extract. A sample of this extract was sent to the BIO Shield Program for testing at a top security lab located in Ft. Dietrich, MD. The BIO Shield Program is a division within the Defense Department created to search for remedies against biological warfare agents and bioterrorism threats - e.g. pathogens like smallpox or anthrax.

Several tens of thousands of natural and synthetic "medicines" have been tested within the Bio Shield Program. According to John Seacrest, drug discovery supervisor within BIO Shield, the agarikon extract submitted by Paul Stamets was one of only a few agents that tested positive against viruses related to smallpox. While smallpox virus itself is not available for testing (due to it being supposedly extinct and all), the agarikon extract proved effective in inhibiting closely related viruses (presumably cowpox).

Following this discovery, Paul Stamets now has a patent pending on a mushroom-derived anti-viral drug. One of his financial backers, Boston-based investor John Norris, bases his support in part on the fact that, as he says, not everyone is able or willing to be vaccinated against diseases such as smallpox.

A former second in command at the FDA, Mr. Norris is hopeful that he and Paul Stamets will be able to sell hundreds of millions of doses of this agarikon extract to the American, German and British armies' defense stock-piles.

However, that may still be a few years off. This new mushroom-based anti-viral drug must first go through many lab trials and then gain final approval by the FDA.

Note: The above article is intended for informational purposes only. Agarikon has not been approved by the FDA for use as a medicinal. Never use any herbal or mushroom-product for medicinal purposes unless advice to do so by a licensed medical practitioner.

Reference: Tom Banse, NPR Morning Edition, Smallpox Defense May Be Found in Mushrooms, August 4, 2005. - 17274

About the Author:

About the author: Dr. Rafael has worked in natural health since the mid-90's, specializing in medicinal mushrooms. Click Agarikon Mushroom for agarikon-photo, mushroom products, free mushroom articles, or to request unique copies of medicinal mushroom articles for your own web-site or magazine / ezine. Click Fomitopsis officinalis for scientific references about agarikon.